11. ASSOCIATION OF BONE MINERAL DENSITY AND SOME FEATURES IN CIRRHOTIC PATIENTS
Main Article Content
Abstract
Objective: To investigate the relationship between bone density and clinical and paraclinical factors in patients with cirrhosis.
Materials and methods: A cross-sectional descriptive analysis involving 33 patients with cirrhosis at the Department of Internal Medicine - Endocrinology - Musculoskeletal, Hue University of Medicine and Pharmacy Hospital. The study was conducted from April 12, 2024 to November 25, 2024. Bone mineral density was measured by the Medix DR machine in the lumbar spine L1-L4 and the femoral neck of the non-dominant leg.
Results: At the femoral neck, 42.4% of patients had osteopenia, and 12.1% had osteoporosis. At the lumbar spine, the rates were 42.4% for osteopenia and 27.3% for osteoporosis. The average bone density mineral for both the femoral neck and lumbar spine was was significantly lower in individuals aged 55 and older compared to those younger than 55 (p < 0.05). The risk of osteopenia or osteoporosis at the lumbar spine and femoral neck was 5.71 times and 5.5 times higher, respectively, for the group aged 55 and older compared to the younger group (p < 0.05). Individuals who consumed alcohol heavily had lower average bone density at both the femoral neck and lumbar spine (p < 0.05). A significant difference was also observed in the average Child-Pugh score and the bone density at the lumbar spine (p = 0.04).
Conclusion: Bone mineral density is influenced by various factors, including age, alcohol consumption, and the Child-Pugh score in patients with cirrhosis. It is advisable to increase the study sample size and to routinely assess bone density in this population.
Article Details
Keywords
Cirrhosis, bone mineral density, osteoporosis, DXA.
References
[2] Lupoli R, Di Minno A, Spadarella G, Ambrosino P, Panico A, Tarantino L et al, The risk of osteoporosis in patients with liver cirrhosis: a meta-analysis of literature studies, Clinical Endocrinology, 2016, 84 (1): 30-8.
[3] Collier J, Bone disorders in chronic liver disease, Hepatology, 2007, 46 (4): 1271-8.
[4] Patel N, Muñoz S.J, Bone disease in cirrhosis, Clinical Liver Disease, 2015, 6 (4): 96-9.
[5] Angulo P, Therneau T.M, Jorgensen R.A, DeSotel C.K, Egan K.S, Dickson E.R et al, Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression, Journal of Hepatology, 1998, 29 (5): 729-35.
[6] Sokhi R.P, Anantharaju A, Kondaveeti R, Creech S.D, Islam K.K, Van Thiel D.H, Bone mineral density among cirrhotic patients awaiting liver transplantation, Liver Transplantation, 2004, 10 (5): 648-53.
[7] Gallego-Rojo F.J, Gonzalez-Calvin J.L, Muñoz-Torres M, Mundi J.L, Fernandez-Perez R, Rodrigo-Moreno D, Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis, Hepatology, 1998, 28 (3): 695-9.
[8] Long R.G, Meinhard E, Skinner R.K, Varghese Z, Wills M.R, Sherlock S, Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease, Gut, 1978, 19 (2): 85.
[9] Guañabens N, Parés A, Mariñoso L, Ma B, Piera C, Serrano S et al, Factors influencing the development of metabolic bone disease in primary biliary cirrhosis, The American journal of gastroenterology, 1990, 85 10: 1356-62.
[10] Meys E, Fontanges E, Fourcade N, Thomasson A, Pouyet M, Delmas P.D, Bone loss after orthotopic liver transplantation, The American Journal of Medicine, 1994, 97 (5): 445-50.
[11] Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martinez de Osaba M.J et al, Osteoporosis and Bone Mineral Metabolism Disorders in Cirrhotic Patients Referred for Orthotopic Liver Transplantation, Calcified Tissue International, 1997, 60 (2): 148-54.
[12] World Health Organition, Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group [meeting held in Rome from 22 to 25 June 1992], Geneva: World Health Organization, 1994.
[13] Trần Thị Thu Hà, Nguyễn Thị Thu Thảo, Lê Thị Huệ, Mối liên quan giữa yếu tố nguy cơ loãng xương với nguy cơ gãy xương, Tạp chí Y học TP Hồ Chí Minh, 2016, 20 (6): 132-7.
[14] Hansen S.A, Folsom A.R, Kushi L.H, Sellers T.A, Association of fractures with caffeine and alcohol in postmenopausal women: the Iowa Women's Health Study, Public Health Nutr, 2000, 3 (3): 253-61.
[15] Turkeli M, Dursun H, Albayrak F, Okçu N, Uyanik M.H, Uyanik A et al, Effects of cirrhosis on bone mineral density and bone metabolism, Eurasian J Med, 2008, 40 (1): 18-24.
[16] De A, Ray D, Lamoria S, Sharma V, Khurana T.R, Hepatic osteodystrophy and fracture risk prediction using FRAX tool in Indian patients with cirrhosis, JGH Open, 2020, 4 (5): 945-9.
[17] Ionele C.M, Turcu-Stiolica A, Subtirelu M.S, Ungureanu B.S, Sas T.N, Rogoveanu I, Osteoporosis Assessment among Adults with Liver Cirrhosis, Journal of Clinical Medicine, 2023, 12 (1): 153.
[18] Meena P.D, Singh A, Nawal C.L, Chejara R.S, Jain S, Bansal P.K, Relation of bone mineral density with severity of liver cirrhosis. International Journal of Advances in Medicine, 2018, 5 (4): 809-13.
[19] George J, Ganesh H.K, Acharya S, Bandgar T.R, Shivane V, Karvat A et al, Bone mineral density and disorders of mineral metabolism in chronic liver disease, World J Gastroenterol, 2009, 15 (28): 3516-22.